Wellness & Tox Lab

South East, USA

Short Summary

Biostat Laboratories is a full service Tox & Blood Lab housed in a brand new 5,000 square ft building with state of the art equipment and strong technology infrastructure.

Highlights

  • Existing call service selling ad on service to over 100,000 clients
  • All equipment validated
  • Strong/qualified medical director to run lab operation
  • Owner has plenty of skin in the game
  • Strong sells and marketing team already
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
US$1,000,000
Minimum
US$200,000
Investment Raised
N/A
Previous Rounds N/A
Stage Pre-Startup/R&D
Investor Role

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 198,797 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Featured
6% raised

Trillium Eye Care Pre-IPO

location_on South East, USA

Join this international health care group expand clinics in North America. Convertible Note pays 10% interest which converts into Stock pre-IPO. Company is targeting an IPO in the US.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

Global Pro
0% raised

CBD TV!

location_on West, USA

Our CBD products have been chosen by Shark Tank's Kevin Harrington to produce our very own DRTV commercial featuring our unique difference in the marketplace. At NOHI, we support complete healing through education, co-creation, and empowerment.

US$ 25,000

Target

US$ 500

Min per Investor

Global Pro
0% raised

New Rotator Cuff Product

location_on North East, USA

We have issued patents for a new breakthrough technology that will greatly improve the standard of care for rotator cuff tears and at the same time reduce medical spending. This investment will bring this new product to the FDA for approval.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

load one similar proposal